These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5004598)

  • 1. In vitro behavior of macrophages from healthy persons against M. leprae and other mycobacteria.
    Delville J
    Int J Lepr Other Mycobact Dis; 1971; 39(2):329-39. PubMed ID: 5004598
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of Mycobacterium leprae-specific uptake in Schwann cells.
    Band AH; Bhattacharya A; Talwar GP
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):71-8. PubMed ID: 3086468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolytic enzymes in macrophages from leprosy patients in presence of Mycobacterium leprae.
    Marolia J; Mahadevan PR
    Indian J Lepr; 1984; 56(4):776-83. PubMed ID: 6398340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage interaction with mycobacteria including M. leprae.
    Ryter A; Frehel C; Rastogi N; David HL
    Acta Leprol; 1984; 2(2-4):211-26. PubMed ID: 6398582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of lysosomal enzymes in macrophages. III. Lysosomal enzyme activities in cultured macrophages infected with some species of mycobacteria.
    Katoh M
    Hiroshima J Med Sci; 1981 Jun; 30(2):99-107. PubMed ID: 7028685
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycobacteria and lysosomes: a paradox.
    Brown CA; Draper P; Hart PD
    Nature; 1969 Feb; 221(5181):658-60. PubMed ID: 4975468
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical alteration in cells following phagocytosis of M. leprae--the consequence--a basic concept.
    Mahadevan PR; Antia NH
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):167-71. PubMed ID: 6995358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytosis of Mycobacterium leprae by cardiac muscle cells--a preliminary report.
    Job CK; McCormick GM; Moses RL; Hastings RC
    Indian J Lepr; 1990; 62(1):55-9. PubMed ID: 2193061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature of peritoneal macrophages from DCC immunized mice.
    Damle A; Mahadevan PR
    Indian J Lepr; 1993; 65(4):405-14. PubMed ID: 8182287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodic acid-Schiff reaction stains Mycobacterium tuberculosis, Mycobacterium leprae, Mycobacterium ulcerans, Mycobacterium chelonei (abscessus), and Mycobacterium kansasii.
    Wear DJ; Hadfield TL; Connor DH; Neafie RC; Banks IS; Meyers WM; Binford CH
    Arch Pathol Lab Med; 1985 Aug; 109(8):701-3. PubMed ID: 3925927
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vitro behavior of macrophages of healthy subjects and Hansen patients against Mycobacterium leprae].
    Freire-Maia DV
    Hansenol Int; 1983 Dec; 8(2):81-90. PubMed ID: 6381301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the lipids of "Mycobacterium gordonae" in comparison with those of "M. leprae" and of some other scotochromogenic mycobacteria (author's transl)].
    Daffé M; Lanéelle MA; Promé D; Asselineau C
    Ann Microbiol (Paris); 1981; 132B(1):3-12. PubMed ID: 7030172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effect of delipidified cell component of Mycobacterium leprae in relation to infection with leprosy bacteria in mice.
    Damle A; Mahadevan PR
    Indian J Lepr; 1993; 65(3):271-82. PubMed ID: 8283062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipids from Mycobacterium leprae cell wall are endowed with an anti-inflammatory property and inhibit macrophage function in vivo.
    Moura AC; Mariano M
    Immunology; 1996 Dec; 89(4):613-8. PubMed ID: 9014830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro behavior of blood derived macrophages against killed M. leprae.
    Pisani RC; Beiguelman B; Opromolla DV
    Int J Lepr Other Mycobact Dis; 1973; 41(1):14-24. PubMed ID: 4582838
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycoside-bearing liposomal delivery systems against macrophage-associated disorders involving Mycobacterium leprae and Mycobacterium tuberculosis.
    Medda S; Das N; Mahato SB; Mahadevan PR; Basu MK
    Indian J Biochem Biophys; 1995 Jun; 32(3):147-51. PubMed ID: 7590855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacteria-macrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.
    Stokes RW; Haidl ID; Jefferies WA; Speert DP
    J Immunol; 1993 Dec; 151(12):7067-76. PubMed ID: 8258711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Culture and phagocytic characteristics of Schwann cells in vitro. A possible model substrate for cultivation of M. leprae.
    Lalitha VS; Bapat CV; Dastur DK
    Int J Lepr Other Mycobact Dis; 1977; 45(3):266-72. PubMed ID: 336557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of lymphokine-activated killer cells to lyse mycobacteria-infected cells.
    Chiplunkar SV; Deshmukh MA; Kode JA; Gangal SG; Deo MG
    Acta Leprol; 1997; 10(4):203-8. PubMed ID: 9447253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.